The new solution generates required data in the appropriate format to be submitted to the U.S. Food and Drug Administration’s Global UDI Database, a requirement of the UDI rule. The solution also tracks FDA response to each submission. Additionally, the solution can pre-validate GUDID submissions according to the FDA’s specifications, allowing manufacturers to address any issues prior to final submission, according to a GHX news release.
More Articles on the UDI Rule:
Drug Supply Chain & Security Act Implementation Timeline
HSCA Files Comments on DSCSA With FDA
GS1 Healthcare US Releases UDI Implementation Guide
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
